Chinese Scientists: Antiviral Drug Effective Against COVID-19

Table of contents:

Chinese Scientists: Antiviral Drug Effective Against COVID-19
Chinese Scientists: Antiviral Drug Effective Against COVID-19

Video: Chinese Scientists: Antiviral Drug Effective Against COVID-19

Отличия серверных жестких дисков от десктопных
Video: Antiviral drug remdesivir shows promise as COVID-19 treatment 2023, January
Anonim

Chinese Scientists: Antiviral Drug Effective Against COVID-19

Perhaps the antiviral drug favipiravir accelerates recovery from COVID-19. The Ministry of Science and Technology of the PRC said that its effectiveness was shown by two small clinical studies, in which 320 people participated.

Chinese Scientists: Antiviral Drug Effective Against COVID-19
Chinese Scientists: Antiviral Drug Effective Against COVID-19

Photo: Xinhua /

Perhaps the antiviral drug favipiravir accelerates recovery from COVID-19. The Ministry of Science and Technology of the PRC said that its effectiveness was shown by two small clinical studies, in which 320 people participated. This is reported by the Guardian with reference to the Japanese media.

Zhang Xingming, a spokesman for the PRC Ministry of Science and Technology, said favipiravir has undergone clinical trials with 320 patients in hospitals in Wuhan (240 people) and Shenzhen (80 people).

“The drug has a high level of safety and is definitely effective in treatment,” Zhang said.

The Japanese broadcaster NHK reported that in Shenzhen, patients stopped shedding coronavirus as early as four days after treatment with the drug. Those who did not receive favipiravir shed the virus for an average of 11 days.

It is reported that the improvement in the condition of patients under the influence of the drug was confirmed by X-ray: images of the lungs became "clearer" in 91% of patients from the experimental group and in 62% of patients who did not receive new treatment.

The Guardian notes that, according to a source in the Japanese Ministry of Health, the drug does not help patients with severe symptoms. “We gave favipiravir to 70 to 80 patients, but it doesn't seem to be as effective when the virus has already multiplied in the body,” a source told the Japanese newspaper Mainichi Shimbun.

Favipiravir was approved in Japan for the treatment of influenza in 2014, but its effectiveness has been questioned. In 2016, the Japanese government sent the drug to Guinea to fight Ebola virus disease.

Favipiravir has not yet received official approval for the treatment of COVID-19.

Popular by topic